Details for 2017158770
Up to date per 03.04.2026
Actions
Details for 2017158770
Granted/Registered
European Patent
16.08.2017 A
12.04.2023 B1
23.04.2010
US
343177 P
26.05.2010
US
396376 P
09.09.2010
US
403011 P
29.10.2010
US
456014 P
13.01.2011
US
201161432372 P
A61K 38/46 20060101AFI20220805BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
Representative
Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WIENAT
Inventor
QUINN, Anthony21 Fort Hill Avenue Gloucester, MA 01930US
HARVEY, Alex160 Fox Trce. Athens, GA 30606US
Information about Fees